Michael Geffner
Hoofd Techniek/Wetenschap/O&O bij IMMUNOVANT, INC.
Vermogen: 4 M $ op 31-05-2024
Oorsprong van het eerstegraads netwerk van Michael Geffner
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 21 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Michael Geffner via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Immunovant Sciences Ltd.
 Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chairman Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal | |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal President | |
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| EARGO, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
| IMMUNOMEDICS, INC. | Biotechnology | Investor Relations Contact Chief Tech/Sci/R&D Officer | |
Lilly Research Laboratories
 Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Aruvant Sciences, Inc.
 Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
NeoTract, Inc.
 NeoTract, Inc. BiotechnologyHealth Technology NeoTract, Inc. develops surgical devices for urological and gynecological disorders. It offers UroLift System, a minimally invasive device to treat lower urinary tract symptoms due to benign prostatic hyperplasia. The company was founded by Joshua Makower, Joseph Catanese, Theodore C. Lamson and Earl A. Bright II in 2004 and is headquartered in Pleasanton, CA. | Biotechnology | Director of Finance/CFO Director/Board Member | |
| FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel | |
| ATHENAHEALTH, INC | Packaged Software | Corporate Officer/Principal | |
Flexion, Inc.
 Flexion, Inc. Information Technology ServicesTechnology Services Flexion, Inc. is an American company that offers services to help businesses with digital transformation, innovative development, and modernization. The private company provides IT staffing and work to improve the efficiency, security, and user experience of their clients' systems. Flexion uses a rigorous agile practice to build flexible solutions that enable their clients' businesses to grow. | Information Technology Services | General Counsel | |
| Washington University School of Law | College/University | Graduate Degree | |
| The University of Nebraska-Lincoln | College/University | Doctorate Degree | |
| University of Iowa | College/University | Graduate Degree | |
| MINERVA NEUROSCIENCES, INC. | Pharmaceuticals: Major | General Counsel | |
| State University of New York at Binghamton | College/University | Undergraduate Degree | |
| The University of North Carolina at Chapel Hill | College/University | Undergraduate Degree | |
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Pharmaceuticals: Major | Director/Board Member | |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Pharmaceuticals: Major | Chairman | |
Dermavant Sciences Ltd.
 Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Respivant Sciences, Inc.
 Respivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Respivant Sciences, Inc. is a clinical-stage biopharmaceutical company that develops therapies for patients with respiratory diseases. The company is based in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
New Enterprise Associates LLC
 New Enterprise Associates LLC Investment ManagersFinance New Enterprise Associates LLC is an alternative investment manager. The private company is based in Timonium, MD. The company was founded in 1978 by Chuck Newhall, C. Richard Kramlich. | Investment Managers | Corporate Officer/Principal | |
| UNC School of Medicine | College/University | Doctorate Degree | |
Altavant Sciences, Inc.
 Altavant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Altavant Sciences, Inc. is a clinical stage biopharmaceutical company, which provides therapies that treat respiratory diseases with an initial therapeutic focus in pulmonary arterial hypertension (PAH). The company is headquartered in Cary, NC. | Pharmaceuticals: Major | Director/Board Member | |
Immunetrics, Inc.
 Immunetrics, Inc. BiotechnologyHealth Technology Immunetrics, Inc. operates as a bio-simulation company. The company was founded by Carson Chow, Timothy R. Billiar, Gilles Clermont, Mitchell P. Fink and Yoram Vodovotz in 2001 and is headquartered in Pittsburgh, PA. | Biotechnology | Director/Board Member | |
Point32health Services, Inc.
 Point32health Services, Inc. Life/Health InsuranceFinance Tufts Associated Health Plans, Inc. provides healthcare plans. It offers health care coverage options to individuals and employer groups. The firm also offers choice tiered network option plan and Steward Community Choice, a community-based plan, developed in conjunction with Steward Health Care System. The company was founded by Morton A. Madoff in 1979 and is headquartered in Watertown, MA. | Life/Health Insurance | Director/Board Member | |
Genevant Sciences Corp.
 Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Pharmaceuticals: Major | Chairman | |
| Focus Biomedical Consulting LLC | Chief Executive Officer | ||
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Yale School of Medicine | College/University | Doctorate Degree | |
| Marquette University | College/University | Undergraduate Degree | |
| The Indiana University School of Medicine | College/University | Corporate Officer/Principal | |
Roivant Sciences GmbH
 Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chief Operating Officer | |
| St. Louis College of Pharmacy | College/University | Doctorate Degree | |
| University of Pennsylvania | College/University | Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Masters Business Admin | |
| Rush University | College/University | Graduate Degree | |
| Medical University of Lublin | College/University | Graduate Degree | |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal | |
| Queen's University of Belfast | College/University | Graduate Degree | |
| AMICUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistieken
Internationaal
| Verenigde Staten | 43 |
| Verenigd Koninkrijk | 4 |
| Bermuda | 2 |
| Canada | 2 |
| België | 2 |
Sectoraal
| Health Technology | 28 |
| Consumer Services | 17 |
| Finance | 4 |
| Technology Services | 3 |
| Commercial Services | 2 |
Operationeel
| Director/Board Member | 62 |
| Corporate Officer/Principal | 31 |
| Independent Dir/Board Member | 16 |
| Undergraduate Degree | 15 |
| Chief Tech/Sci/R&D Officer | 15 |
Sterkste connecties
| Insiders | |
|---|---|
| Frank Torti | 35 |
| Atul Pande | 20 |
| George Migausky | 18 |
| Andrew Fromkin | 16 |
| Douglas Hughes | 15 |
| Eric Venker | 12 |
| Peter Salzmann | 10 |
| Mark Levine | 8 |
| William L. Macias | 7 |
| Jay Stout | 5 |
| Ian Gourley | 5 |
| Eva Barnett | 4 |
| Sheetal Patel | 4 |
| Julia G. Butchko | 4 |
| Lauren Schrier | 4 |
- Beurs
- Insiders
- Michael Geffner
- Bedrijfsconnecties
